Abstract
Background: Patients with mood disorder, both unipolar and bipolar, present with significant cognitive dysfunction while unwell and this persists into euthymia. This impairment is to an extent independent of mood symptoms, has significant implications for prognosis, and exerts an effect on overall functioning. Neurobiological data suggest that the cognitive dysfunction may relate to underlying dysfunction of pre-frontal cortical areas of the brain and their connections with limbic structures.
Methods: In this paper we examine the theoretical and neurobiological rationale for psychological treatments which focus on the treatment of cognitive dysfunction. We systematically review preliminary studies using cognitive rehabilitation (CR) based techniques in mood disorders, focussing on clinical contexts in which CR may be particularly likely to be important. In addition we examine important methodological issues in developing such an approach.
Results: There is little evidence of traditional psychotherapies having a beneficial effect on cognitive function. However, there are a small number of studies examining specific CR in major depression and in bipolar disorder. The studies are small and inconclusive. However data on neuropsychological function and neurobiology of major depression suggest that this is an approach which deserves further attention and research.
Conclusion: Further research is required in carefully selected populations, using well defined CR techniques and appropriate comparator treatments. Combination of these techniques with pharmacological and broader psychological treatments is likely to be most effective.
Keywords: Bipolar disorder, clinical trials, cognition, depression, mood disorders, psychological treatment.
CNS & Neurological Disorders - Drug Targets
Title:Psychological Treatments for Cognitive Dysfunction in Major Depressive Disorder: Current Evidence and Perspectives§
Volume: 13 Issue: 10
Author(s): Richard J. Porter, Katie Douglas, Jennifer Jordan, Christopher R. Bowie, Jonathan Roiser and Gin S. Malhi
Affiliation:
Keywords: Bipolar disorder, clinical trials, cognition, depression, mood disorders, psychological treatment.
Abstract: Background: Patients with mood disorder, both unipolar and bipolar, present with significant cognitive dysfunction while unwell and this persists into euthymia. This impairment is to an extent independent of mood symptoms, has significant implications for prognosis, and exerts an effect on overall functioning. Neurobiological data suggest that the cognitive dysfunction may relate to underlying dysfunction of pre-frontal cortical areas of the brain and their connections with limbic structures.
Methods: In this paper we examine the theoretical and neurobiological rationale for psychological treatments which focus on the treatment of cognitive dysfunction. We systematically review preliminary studies using cognitive rehabilitation (CR) based techniques in mood disorders, focussing on clinical contexts in which CR may be particularly likely to be important. In addition we examine important methodological issues in developing such an approach.
Results: There is little evidence of traditional psychotherapies having a beneficial effect on cognitive function. However, there are a small number of studies examining specific CR in major depression and in bipolar disorder. The studies are small and inconclusive. However data on neuropsychological function and neurobiology of major depression suggest that this is an approach which deserves further attention and research.
Conclusion: Further research is required in carefully selected populations, using well defined CR techniques and appropriate comparator treatments. Combination of these techniques with pharmacological and broader psychological treatments is likely to be most effective.
Export Options
About this article
Cite this article as:
Porter J. Richard, Douglas Katie, Jordan Jennifer, Bowie R. Christopher, Roiser Jonathan and Malhi S. Gin, Psychological Treatments for Cognitive Dysfunction in Major Depressive Disorder: Current Evidence and Perspectives§, CNS & Neurological Disorders - Drug Targets 2014; 13 (10) . https://dx.doi.org/10.2174/1871527313666141130223248
DOI https://dx.doi.org/10.2174/1871527313666141130223248 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Heart and Brain Axis Targets in CNS Neurological Disorders
Recently there has been a surge of interest in delving deeper into the complex interplay between the heart and brain. This fascination stems from a growing recognition of the profound influence each organ holds over the other, particularly in the realm of central nervous system (CNS) neurological disorders. The purpose ...read more
Lifestyle Interventions to Prevent and Treat Cognitive Impairment and Dementia
More than 55 million people live with dementia worldwide. By 2050, the population affected by dementia will exceed 139 million individuals. Mild cognitive impairment (MCI) is a pre-dementia stage, also known as prodromal dementia, affecting older adults. MCI emerges years before the manifestation of dementia but can be avoidable and ...read more
Pathogenic Proteins in Neurodegenerative Diseases: From Mechanisms to Treatment Modalities
The primary objective of this thematic issue is to elucidate the molecular mechanisms by which pathogenic proteins contribute to neurodegenerative diseases and to highlight current and emerging therapeutic strategies aimed at mitigating their effects. By bringing together cutting-edge research and reviews, this issue aims to: 1.Enhance Understanding: Provide a comprehensive ...read more
Role of glial cells in autism spectrum disorder: Molecular mechanism and therapeutic approaches
Emerging evidence suggests that glial cells may play a pivotal role in neuroanatomical and behavioral changes found in autism spectrum disorder (ASD). Many individuals with ASD experience a neuro-immune system abnormalities throughout life, which implicates a potential role of microglia in the pathogenesis of ASD. Dysfunctional astrocytes and oligodendrocytes were ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Von Willebrand Factor: Drug and Drug Target
Cardiovascular & Hematological Disorders-Drug Targets New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives
Current Pharmaceutical Design Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Current Cardiology Reviews MicroRNAs in Various Body Fluids and their Importance in Forensic Medicine
Mini-Reviews in Medicinal Chemistry Transient Secondary Hypothyroidism and Thyroid Hormone Replacement Therapy in Pediatric Postoperative Cardiopulmonary Bypass
Current Cardiology Reviews Animal Models of Systemic Sclerosis
Current Pharmaceutical Design Lack of Association Between SLC24A4 Polymorphism and Late-onset Alzheimer's Disease in Han Chinese
Current Neurovascular Research Effects of an Outpatient Service Rehabilitation Programme in Patients Affected by Pulmonary Arterial Hypertension: An Observational Study
Cardiovascular & Hematological Disorders-Drug Targets Advances in Anoctamin 1: A Potential New Drug Target in Medicinal Chemistry
Current Topics in Medicinal Chemistry Cardiovascular Effects of Coumarins Besides their Antioxidant Activity
Current Topics in Medicinal Chemistry Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Gene Therapy for Arthritis
Current Drug Targets Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives
Current Pharmaceutical Design Antioxidants as Potentially Safe Antidotes for Organophosphorus Poisoning
Current Enzyme Inhibition Selective Inhibitors of Nuclear Factor of Activated T Cells: Potential Therapeutic Drugs for the Treatment of Immunological and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Intracerebrally Applied Botulinum Neurotoxin in Experimental Neuroscience
Current Pharmaceutical Biotechnology Malondialdehyde and Superoxide Dismutase in High-dose Calcium Supplemented Women in Relation to Iron and Calcium Panels
Current Nutrition & Food Science Leukocyte-Endothelial Cell Interactions: A Therapeutic Target to Ameliorate Inflammatory Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Effect of Statins on the Differentiation and Function of Central Nervous System Cells
Current Medicinal Chemistry Mitochondrial Disorders in Adults
Current Molecular Medicine